The majority of circulating platelet-derived microparticles fail to bind annexin V, lack phospholipid-dependent procoagulant activity and demonstrate greater expression of glycoprotein Ib

Thrombosis and Haemostasis

Volumn 103, Issue 5, 2010, Pages 1044-1052

  Connor, David Ewan ^a,b   Exner, Thomas ^a   Ma, David Dang Fung ^a,b   Joseph, Joanne Emily ^a,b  

^a ST VINCENT S HOSPITAL   (Australia)

^b UNIVERSITY OF NEW SOUTH WALES   (Australia)

Author keywords

Annexin V; Flow cytometry; Microparticles; Phosphatidylserine; XACT

Indexed keywords

BUFFER; CALCIUM; CD40 LIGAND; CD61 ANTIGEN; CD63 ANTIGEN; COLLAGEN; FIBRINOGEN RECEPTOR; GLYCOPROTEIN IB; GLYCOPROTEIN IB ALPHA; IONOPHORE; LIPOCORTIN 5; PADGEM PROTEIN; PHOSPHOLIPID; PROCOAGULANT; LEUKOCYTE ANTIGEN; PHOSPHATIDYLSERINE; PROTEIN BINDING; THROMBIN RECEPTOR;

ARTICLE; BLOOD CLOTTING; CONTROLLED STUDY; FLOW CYTOMETRY; HUMAN; PLATELET MICROPARTICLE; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN EXPRESSION; BIOSYNTHESIS; BLOOD CLOTTING TEST; CELL CULTURE; DRUG EFFECTS; GENETICS; MEMBRANE MICROPARTICLE; METABOLISM; PATHOLOGY; THROMBOCYTE;

ANNEXIN A5; ANTIGENS, CD; BLOOD COAGULATION; BLOOD COAGULATION TESTS; BLOOD PLATELETS; CELL-DERIVED MICROPARTICLES; CELLS, CULTURED; COLLAGEN; FLOW CYTOMETRY; HUMANS; IONOPHORES; PHOSPHATIDYLSERINES; PLATELET GLYCOPROTEIN GPIB-IX COMPLEX; PROTEIN BINDING;

EID: 77952074366     PISSN: 03406245     EISSN: None     Source Type: Journal    
DOI: 10.1160/TH09-09-0644     Document Type: Article

References (30)

1. Sinauridze EI, Kireev DA, Popenko NY, et al. Platelet microparticle membranes have 50- to 100-fold higher specific procoagulant activity than activated platelets. Thromb Haemost 2007; 97: 425-434.
2. Bode AP, Sandberg H, Dombrose FA, et al. Association of factor V activity with membranous vesicles released from human platelets: requirement for platelet stimulation. Thromb Res 1985; 39: 49-61. (Pubitemid 15008440)
3. Huisse MG, Ajzenberg N, Feldman L, et al. Microparticle-linked tissue factor activity and increased thrombin activity play a potential role in fibrinolysis failure in ST-segment elevation myocardial infarction. Thromb Haemost 2009; 101: 734-740.
4. Haubold K, Rink M, Spath B, et al. Tissue factor procoagulant activity of plasma microparticles is increased in patients with early-stage prostate cancer. Thromb Haemost 2009; 101: 1147-1155.
5. Thiagarajan P, Tait JF. Binding of annexin V/placental anticoagulant protein I to platelets. Evidence for phosphatidylserine exposure in the procoagulant response of activated platelets. J Biol Chem 1990; 265: 17420-17423. (Pubitemid 20355878)
6. Ahn YS, Jy W, Jimenez JJ, et al. More on: cellular microparticles: what are they bad or good for? J Thromb Haemost 2004; 2: 1215-1216.
7. Boulanger CM, Amabile N, Tedgui A. Circulating Microparticles. A Potential Prognostic Marker for Atherosclerotic Vascular Disease. Hypertension 2006; 48: 1-7.
8. Dignat-George F, Sabatier F, Camoin-Jau L, et al. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1844-1845.
9. Enjeti AK, Lincz LF, Seldon M. Detection and measurement of microparticles: an evolving research tool for vascular biology. Sem Thromb Haemost 2007; 33: 771-779. (Pubitemid 351158445)
10. Jimenez JJ, Jy W, Mauro LM, et al. Endothelial cells release phenotypically and quantitatively distinct microparticles in activation and apoptosis. Thromb Res 2003; 109: 175-180. (Pubitemid 36712905)
11. Exner T, Joseph J, Low J, et al. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis 2003; 14: 773-779.
12. Connor DE, Exner T, Ma DD, et al. Detection of the procoagulant activity of microparticle-associated phosphatidylserine using XACT. Blood Coagul Fibrinolysis 2009; 20: 558-564.
13. Parsi K, Exner T, Connor DE, et al. In vitro effects of detergent sclerosants on coagulation, platelets and microparticles. Eur J Vasc Endovasc Surg 2007; 34: 731-740.
14. Exner T, Joseph J, Low J, et al. A new activated factor X-based clotting method with improved specificity for procoagulant phospholipid. Blood Coagul Fibrinolysis 2003; 14: 773-779.
15. Biro E, Nieuwland R, Sturk A. Measuring circulating cell-derived microparticles. J Thromb Haemost 2004; 2: 1843-1844.
16. Sandberg H, Bode AP, Dombrose FA, et al. Expression of coagulant activity in human platelets: release of membranous vesicles providing platelet factor 1 and platelet factor 3. Thromb Res 1985; 39: 63-79. (Pubitemid 15008441)
17. Hemker HC, van Rijn JL, Rosing J, et al. Platelet membrane involvement in blood coagulation. Blood Cells 1983; 9: 303-317.
18. Morrissey JH. Tissue factor: an enzyme cofactor and a true receptor. Thromb Haemost 2001; 86: 66-74.
19. Dachary-Prigent J, Freyssinet JM, Pasquet JM, et al. Annexin V as a probe of aminophospholipid exposure and platelet membrane vesiculation: a flow cytometry study showing a role for free sulfhydryl groups. Blood 1993; 81: 2554-2565. (Pubitemid 23147557)
20. Nieuwland R, Berckmans RJ, Rotteveel-Eijkman RC, et al. Cell-derived microparticles generated in patients during cardiopulmonary bypass are highly procoagulant. Circulation 1997; 96: 3534-3541. (Pubitemid 27513430)
21. Thiagarajan P, Tait JF. Collagen-induced exposure of anionic phospholipid in platelets and platelet-derived microparticles. J Biol Chem 1991; 266: 24302-24307. (Pubitemid 21908941)
22. Perez-Pujol S, Marker PH, Key NS. Platelet microparticles are heterogeneous and highly dependent on the activation mechanism: studies using a new digital flow cytometer. Cytometry 2007; 71: 38-45. (Pubitemid 46207382)
23. Becker CK, Parker JW, Hechinger MT. Is forward scatter monotonic on commercial flow cytometers? ISAC, XXI COngress, San Diego, CA. Cytometry 2002; 47 (Suppl 11): Abstract.
24. Shapiro HM. Parameters and Probes. In: Shapiro HM, editor. Practical Flow Cytometry. Fourth Edition ed. John Wiley and Sons Inc., New York; 2003; pp. 273-410.
25. Chow TW, Hellums JD, Thiagarajan P. Thrombin receptor activating peptide (SFLLRN) potentiates shear-induced platelet microvesiculation. J Lab Clin Med 2000; 135: 66-72. (Pubitemid 30042155)
26. Jy W, Horstman LL, Arce M, et al. Clinical significance of platelet microparticles in autoimmune thrombocytopenias. J Lab Clin Med 1992; 119 334-345.
27. Comfurius P, Senden JM, Tilly RH, et al. Loss of membrane phospholipid asymmetry in platelets and red cells may be associated with calcium-induced shedding of plasma membrane and inhibition of aminophospholipid translocase. Biochim Biophys Acta 1990; 1026: 153-160. (Pubitemid 20230019)
28. Andree HA, Stuart MC, Hermens WT, et al. Clustering of lipid-bound annexin V may explain its anticoagulant effect. J Biol Chem 1992; 267: 17907-17912.
29. Zdebska E, Wozniak J, Dzieciatkowska A, et al. In comparison to progenitor platelets, microparticles are deficient in GpIb, GpIb-derived carbohydrates, glycerophospholipids, glycosphingolipids, and ceramides. Acta Biochim Pol 1998; 45: 417-428.
30. Heijnen HF, Schiel AE, Fijnheer R, et al. Activated platelets release two types of membrane vesicles: microvesicles by surface shedding and exosomes derived from exocytosis of multivesicular bodies and alpha-granules. Blood 1999; 94: 3791-3799.